ArticleThe American journal of case reports2025
Post-COVID-19 Painless Thyroiditis: A Case Study on Thyrotoxicosis Management.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Painless thyroiditis is a rare variant of thyroiditis characterized by low thyroid-stimulating hormone (TSH) levels and normal or elevated T4 concentrations, without clinical signs of acute inflammation. While thyroiditis, including subacute and atypical forms, has been associated with many viral infections including SARS-CoV-2, the occurrence of painless thyroiditis after acute COVID-19 remains uncommon. CASE REPORT We describe the case of a 67-year-old man with history of hypertension, diabetes, and myocardial infarction who presented with a 4-week history of decreased appetite, nausea, weight loss, and upper-extremity tremors. He reported having a resolved case of COVID-19 2 months previously. Laboratory evaluation revealed a low TSH level (0.01 mIU/L) and elevated free T4 (>7.7 µg/dL), with negative thyroid-stimulating and thyroid peroxidase antibodies. A neck ultrasound showed a normal thyroid gland. The patient was diagnosed with post-COVID-19 painless thyroiditis and managed with beta blockers, methimazole, and corticosteroids. His symptoms improved significantly during hospitalization, and he was discharged with follow-up plans to monitor for potential hypothyroidism. CONCLUSIONS This case highlights the importance of considering post-COVID-19 painless thyroiditis in patients presenting with thyrotoxicosis and a history of COVID-19. Prompt recognition and treatment with beta blockers, anti-thyroid drugs, and corticosteroids can lead to symptom resolution. Regular follow-up is crucial to detect and manage potential long-term thyroid dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.